Correlation Between NRx Pharmaceuticals and Roivant Sciences
Can any of the company-specific risk be diversified away by investing in both NRx Pharmaceuticals and Roivant Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRx Pharmaceuticals and Roivant Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRx Pharmaceuticals and Roivant Sciences, you can compare the effects of market volatilities on NRx Pharmaceuticals and Roivant Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRx Pharmaceuticals with a short position of Roivant Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRx Pharmaceuticals and Roivant Sciences.
Diversification Opportunities for NRx Pharmaceuticals and Roivant Sciences
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between NRx and Roivant is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding NRx Pharmaceuticals and Roivant Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roivant Sciences and NRx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRx Pharmaceuticals are associated (or correlated) with Roivant Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roivant Sciences has no effect on the direction of NRx Pharmaceuticals i.e., NRx Pharmaceuticals and Roivant Sciences go up and down completely randomly.
Pair Corralation between NRx Pharmaceuticals and Roivant Sciences
Assuming the 90 days horizon NRx Pharmaceuticals is expected to generate 9.84 times more return on investment than Roivant Sciences. However, NRx Pharmaceuticals is 9.84 times more volatile than Roivant Sciences. It trades about 0.07 of its potential returns per unit of risk. Roivant Sciences is currently generating about 0.14 per unit of risk. If you would invest 22.00 in NRx Pharmaceuticals on September 4, 2024 and sell it today you would lose (16.90) from holding NRx Pharmaceuticals or give up 76.82% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 9.71% |
| Values | Daily Returns |
NRx Pharmaceuticals vs. Roivant Sciences
Performance |
| Timeline |
| NRx Pharmaceuticals |
| Roivant Sciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
NRx Pharmaceuticals and Roivant Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NRx Pharmaceuticals and Roivant Sciences
The main advantage of trading using opposite NRx Pharmaceuticals and Roivant Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRx Pharmaceuticals position performs unexpectedly, Roivant Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roivant Sciences will offset losses from the drop in Roivant Sciences' long position.| NRx Pharmaceuticals vs. Candel Therapeutics | NRx Pharmaceuticals vs. Cingulate Warrants | NRx Pharmaceuticals vs. Unicycive Therapeutics | NRx Pharmaceuticals vs. Cardio Diagnostics Holdings |
| Roivant Sciences vs. Roivant Sciences | Roivant Sciences vs. Jasper Therapeutics | Roivant Sciences vs. Humacyte | Roivant Sciences vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |